ClinicalTrials.gg
CompletedNCT00657293Updated Feb 22, 2010

Arm Training in Patients With Chronic Obstructive Pulmonary Disease

An interventional study of Arm training program and Purdue pegboard test (sham) in Chronic Obstructive Pulmonary Disease, sponsored by West Park Healthcare Centre. Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2010-02-22.

Sponsored by West Park Healthcare Centre · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Sex
All
01

Study summary

Patients with chronic lung disease often report shortness of breath when they use their arms for simple activities of daily living such as dressing, lifting, shaving, bathing and brushing their hair and teeth. The best type of arm training for these patients is still unknown.

The objectives of this study are to:

  • develop a feasible and safe arm training program (ATP) for these patients;
  • examine the effects of this ATP on quality of life, arm function, arm exercise capacity and symptoms during activities of daily living;
  • examine the effects of ATP on breathing responses during arm exercises.
Read the detailed description

Chronic obstructive pulmonary disease (COPD) is a common condition throughout Canada and the rest of the world. Patients with COPD often describe of breathlessness that makes it difficult for them to participate in physical activity. Specifically, patients often report shortness of breath when they use their arms for simple activities of daily living such as dressing, lifting and bathing. Exercise training has been shown to reduce breathlessness in people with COPD. Compared with studies that have looked at the effects of exercise using the leg muscles, studies that focus on training the arm muscles in people with COPD are sparse. Although earlier work shows that arm training increases arm exercise capacity, the effects on other measures such as breathlessness are not clear. Therefore, the objectives of this study are; (i) to develop a feasible and safe arm training program (ATP) for patients with COPD based on the best available evidence, (ii) to examine the effectiveness of this ATP on breathlessness during activities of daily living, health-related quality of life, arm function and arm exercise capacity, (iii) to examine the physiological mechanisms underpinning any change in these outcomes in response to the ATP.

Patients with COPD will be assigned by chance to either a treatment or control group. All patients in both groups will complete the 6-week pulmonary rehabilitation (PR) program that is well-established at our centre (West Park). During this program all patients will complete leg exercises, such as walking or cycling, and receive education about how to best manage their disease. In addition to this PR program, the treatment group will complete a specific ATP involving overhead arm exercises and free weights. The control group will undergo a "sham" ATP consisting of finger exercises. Before and after the ATP we will collect measures of; (i) breathlessness during activities of daily living, fatigue and quality of life, (ii) arm exercise capacity, (iii) arm function and, (iv) arm muscle force. During the tests of arm exercise capacity a special machine (breathing-gas analysis system) will be worn. Measurements will be compared between the treatment and control groups before, immediately after the ATP and also 3 months after completing the ATP.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • COPD
  • arm training
  • dyspnoea
  • quality of life
03

In context

Pulmonary Disease, Chronic Obstructive

4,252 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 707 are open to participants now.

This study's enrollment of 34 is below the median of 70 across 3,008 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.

Browse Pulmonary Disease, Chronic Obstructive studies →

Lead sponsor

West Park Healthcare Centre is the lead sponsor of 28 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • a diagnosis of COPD
  • a forced expiratory volume in one second (FEV1) of less than 80% the predicted normal value
  • must report dyspnoea during at least one activity of daily living that requires arm activity
  • must have a smoking history greater than 10 pack years and
  • must be able to provide written informed consent

Exclusion criteria

Exclusion Criteria:

  • acute exacerbation of COPD that required a change in pharmacological management within the preceding two months
  • an inability to understand English
  • cognitive impairment
  • requirement for mechanical ventilation for all or part of the day
  • tapering doses of oral corticosteroids or xanthines
  • evidence of a musculoskeletal or neurological condition which could adversely affect arm exercise performance
  • symptomatic ischemic cardiac disease
  • a history of previous lung surgery and alpha1 antitrypsin deficient emphysema
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
34 participants (actual)

Study arms

  • Sham comparator
    C

    In an attempt to make the groups comparable in terms of attention, the control group will receive a sham.

    Behavioral: Purdue pegboard test (sham)

  • Active comparator
    ATP

    Patients will undergo a specific arm training program (ATP).

    Behavioral: Arm training program

Interventions

  • BehavioralArm training program

    Patients will undergo a specific arm training program (ATP) three times a week for the duration of the 6 week program. The ATP will consist predominantly of resistance exercises. Muscle groups targeted during the ATP will include deltoid, biceps and triceps, pectoralis and latissimus. Subjects will train using multi station gym equipment and free weights.

  • BehavioralPurdue pegboard test (sham)

    In an attempt to make the groups comparable in terms of attention, the control group will perform the purdue pegboard test of finger dexterity. The tasks will be performed in a sitting position with the arms supported on a table. This test will consist of 4 timed tasks where as many pins as possible will be placed on a pegboard in a given time. Performance of the pegboard test is likely to improve with practice which may serve to motivate the patients to continue practicing over the 6-week period. Subjects will perform this activity 3 times per week with supervision provided by a physiotherapist.

06

What researchers measure

Primary outcomes

  1. Feasibility measures, dyspnoea during activities of daily living, fatigue, health-related quality of life, unsupported arm exercise capacity, arm function and peripheral muscle force

    Time frame: Primary outcome measures will be collected before PR program, on completion of the PR program (at 6 weeks) and at three months following completion of the PR program.

Secondary outcomes

  1. Peak cardiorespiratory responses during incremental unsupported upper limb exercise test

    Time frame: Secondary outcome measures will be collected before PR program, on completion of the PR program (at 6 weeks) and at three months following completion of the PR program.

07

Study locations

1 site
  • West Park Healthcare Centre
    Toronto, Ontario M6M 2J5, Canada
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2008, a primary completion of Jan 2010 and a completion of Jan 2010. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 8, 2008
First posted
Apr 14, 2008
Start
Jul 2008
Primary completionActual
Jan 2010
CompletionActual
Jan 2010
Last update
Feb 22, 2010
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 22, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00657293
Lead sponsor
West Park Healthcare Centre
First posted
Apr 14, 2008
Start date
Jul 2008
Primary completion
Jan 2010
Completion
Jan 2010
Last update
Feb 22, 2010

Study contacts

Roger Goldstein, M.D.
principal investigator · West Park Healthcare Centre
Dina Brooks, Ph.D.
principal investigator · West Park Healthcare Centre
Tania Janaudis-Ferreira, Msc
study chair · West Park Healthcare Centre
Kylie Hill, Ph.D.
study chair · West Park Healthcare Centre
Tom Dolmage, Msc
study chair · West Park Healthcare Centre
Marla Beauchamp, Msc
study chair · West Park Healthcare Centre
Karin Wadell, Ph.D.
study chair · Umea University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion